Nurix Therapeutics
Nurixâs B-cell cancer drug on partial hold by FDA over manufacturing issues
Anika Sharma
Nurix Therapeutics has temporarily halted a phase 1 trial for its B-cell malignancy drug, NX-2127, as it undertakes a manufacturing ...
Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Anika Sharma
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...
